J Korean Med Sci.  2016 Dec;31(12):1897-1901. 10.3346/jkms.2016.31.12.1897.

Effectiveness of Varicella Vaccination Program in Preventing Laboratory-Confirmed Cases in Children in Seoul, Korea

• Lee YH
• Choe YJ
• Cho SI
• Kang CR
• Bang JH
• Oh MD
• Lee JK

• KMID: 2355616
• DOI: http://doi.org/10.3346/jkms.2016.31.12.1897

Abstract

A universal one-dose varicella vaccination program was introduced in 2005 in Republic of Korea. However, the incidence of varicella in Korea has tripled over the last decade. We conducted a community based 1:1 matched case-control study to assess the effectiveness of one MAV strain-based vaccine and three Oka strain-based vaccines licensed for use in Korea. All cases were children in Seoul, Korea with varicella who were reported to the National Notifiable Disease Surveillance System in Seoul during 2013. The controls were age-matched children with mumps or scarlet fever but no history of varicella. We included 537 cases and 537 controls. The overall effectiveness of one dose of varicella vaccination was 13% (95% confidence interval [CI], −17.3-35.6). Of the four licensed varicella vaccines, only one was highly effective (88.9%; 95% CI, 52.1-97.4). The vaccine effectiveness for the other vaccines were 71.4% (95% CI, −37.5-94.1), −5% (95% CI, −61.9-31.9), and −100% (95% CI, −700-50.0). The overall effectiveness of vaccination was 75.8% (95% CI, 22.8-92.4) in the first year after vaccination and decreased thereafter; the effectiveness became −7.2% (95% CI, −130.9-59.2) in the fourth year after vaccination. Further studies are warranted to investigate reduced effectiveness of varicella vaccines in Korea.

Keyword

Varicella; Chickenpox; Vaccination; Case-Control Study; Matched Case-Control Study; Korea

MeSH Terms

Case-Control Studies
Chickenpox*
Child*
Humans
Incidence
Korea*
Mumps
Republic of Korea
Scarlet Fever
Seoul*
Vaccination*
Vaccines
Vaccines

Figure

• 

  Fig. 1 Subject recruitment procedures for 1:1 matched case-control study.

Reference

1. Kuter BJ, Weibel RE, Guess HA, Matthews H, Morton DH, Neff BJ, Provost PJ, Watson BA, Starr SE, Plotkin SA. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine. 1991; 9:643–647.

2. Reuss AM, Feig M, Kappelmayer L, Siedler A, Eckmanns T, Poggensee G. Varicella vaccination coverage of children under two years of age in Germany. BMC Public Health. 2010; 10:502.

3. Fu C, Wang M, Liang J, Xu J, Wang C, Bialek S. The effectiveness of varicella vaccine in China. Pediatr Infect Dis J. 2010; 29:690–693.

4. Tan HF, Chang CK, Tseng HF, Lin W. Evaluation of the national notifiable disease surveillance system in Taiwan: an example of varicella reporting. Vaccine. 2007; 25:2630–2633.

5. Park B, Lee YK, Cho LY, Go UY, Yang JJ, Ma SH, Choi BY, Lee MS, Lee JS, Choi EH, et al. Estimation of nationwide vaccination coverage and comparison of interview and telephone survey methodology for estimating vaccination status. J Korean Med Sci. 2011; 26:711–719.

6. Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016; 137:e20153741.

7. Bialek SR, Perella D, Zhang J, Mascola L, Viner K, Jackson C, Lopez AS, Watson B, Civen R. Impact of a routine two-dose varicella vaccination program on varicella epidemiology. Pediatrics. 2013; 132:e1134–40.

8. Korea Centers for Disease Control and Prevention. Disease web statistics system [Internet]. accessed on 14 May 2016. Available at http://is.cdc.go.kr/dstat/index.jsp.

9. Cornfield J. A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst. 1951; 11:1269–1275.

10. Niccolai LM, Ogden LG, Muehlenbein CE, Dziura JD, Vázquez M, Shapiro ED. Methodological issues in design and analysis of a matched case-control study of a vaccine’s effectiveness. J Clin Epidemiol. 2007; 60:1127–1131.

11. Oh SH, Choi EH, Shin SH, Kim YK, Chang JK, Choi KM, Hur JK, Kim KH, Kim JY, Chung EH, et al. Varicella and varicella vaccination in South Korea. Clin Vaccine Immunol. 2014; 21:762–768.

12. Liese JG, Cohen C, Rack A, Pirzer K, Eber S, Blum M, Greenberg M, Streng A. The effectiveness of varicella vaccination in children in Germany: a case-control study. Pediatr Infect Dis J. 2013; 32:998–1004.

13. Vázquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, Shapiro ED. Effectiveness over time of varicella vaccine. JAMA. 2004; 291:851–855.

14. Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011; 128:214–220.

15. Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, Gargiullo P, Perella D, Civen R, Seward JF. Changing varicella epidemiology in active surveillance sites--United States, 1995-2005. J Infect Dis. 2008; 197:Suppl 2. S71–5.

16. Sheffer R, Segal D, Rahamani S, Dalal I, Linhart Y, Stein M, Shohat T, Somekh E. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J. 2005; 24:434–437.

17. Vázquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med. 2001; 344:955–960.

18. Hwang KK, Park SY, Kim SJ, Ryu YW, Kim KH. Restriction fragment length polymorphism analysis of varicella-zoster virus isolated in Korea. J Korean Soc Virol. 1991; 21:201–210.

19. Hwang KK, Chun BH, Park HS, Park SY, Kim KH, Moon HM. Marker test for attenuation of varicella-zoster viruses isolated in Korea. J Korean Soc Virol. 1992; 22:105–109.

20. Sohn YM, Park CY, Hwang KK, Woo GJ, Park SY. Safety and immunogenicity of live attenuated varicella virus vaccine (MAV/06 strain). J Korean Pediatr Soc. 1994; 37:1405–1413.

21. Sohn YM, Yu GJ, Kim PK, Kim KY, Park CY, Kim MR, Jeung WK, Hwang KK, Woo GJ, Park SY. Immunogenicity and safety of live attenuated vaccine(MAV/06srtain) on healthy children and immunocompromised children. J Korean Pediatr Soc. 1995; 38:771–777.

22. Kim DJ, Park HS, Lee SY, Park KS, Kim TK, Song YH, Choi J, Han JW, Song YS, Park TJ, et al. Epidemiology of varicella in Korea based on pediatrician’s office practice. J Korean Pediatr Soc. 1997; 40:620–628.

23. Kim MR, Park JS, Kim DH, Lee HR, Park CY. A clinical and epidemiologic study on varicella in children. Korean J Pediatr Infect Dis. 1998; 5:88–95.

24. Choi UY, Huh DH, Kim JH, Kang JH. Seropositivity of varicella zoster virus in vaccinated Korean children and MAV vaccine group. Hum Vaccin Immunother. Forthcoming. 2016.